Cardiac glycoside interactions at 'silent' and at active receptors. Putative biochemical backgrounds and possible clinical relevance.
D000818:Animals; D001921:Brain / Q000378:metabolism; D004077:Digoxin / Q000378:metabolism*; D004347:Drug Interactions; D004789:Enzyme Activation / Q000187:drug effects; D004910:Erythrocyte Membrane / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism*; D011802:Quinidine / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D013552:Swine; D013974:Thyroxine / Q000378:metabolism; D014284:Triiodothyronine / Q000378:metabolism
D011955:Receptors, Drug; D014284:Triiodothyronine; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase; D011802:Quinidine; D013974:Thyroxine